bioAffinity Technologies Inc (BIAF)

Currency in USD
0.294
-0.023(-7.38%)
Closed·
After Hours
0.290-0.004(-1.23%)
·
BIAF Scorecard
Full Analysis
Quickly burning through cash
BIAF is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.2800.316
52 wk Range
0.1642.410
Key Statistics
Prev. Close
0.317
Open
0.305
Day's Range
0.28-0.316
52 wk Range
0.164-2.41
Volume
593.42K
Average Volume (3m)
7.27M
1-Year Change
-87.27%
Book Value / Share
0.08
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIAF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

bioAffinity Technologies Inc Company Profile

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person’s sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.

Compare BIAF to Peers and Sector

Metrics to compare
BIAF
Peers
Sector
Relationship
P/E Ratio
−0.8x−2.6x−0.5x
PEG Ratio
−0.04−0.080.00
Price/Book
5.6x5.8x2.6x
Price / LTM Sales
0.9x5.0x3.2x
Upside (Analyst Target)
-795.5%43.8%
Fair Value Upside
Unlock26.7%8.1%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 0.000

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-0.16 / -0.17
Revenue / Forecast
1.90M / 2.62M
EPS Revisions
Last 90 days

BIAF Income Statement

People Also Watch

0.130
GTI
-9.12%
0.92
KLTO
-4.55%
0.600
WINT
-11.11%
0.8849
GNS
-13.25%
5.140
GVH
-8.87%

FAQ

What Stock Exchange Does bioAffinity Technologies Trade On?

bioAffinity Technologies is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for bioAffinity Technologies?

The stock symbol for bioAffinity Technologies is "BIAF."

What Is the bioAffinity Technologies Market Cap?

As of today, bioAffinity Technologies market cap is 8.73M.

What Is bioAffinity Technologies's Earnings Per Share (TTM)?

The bioAffinity Technologies EPS (TTM) is -0.71.

When Is the Next bioAffinity Technologies Earnings Date?

bioAffinity Technologies will release its next earnings report on 18 Aug 2025.

From a Technical Analysis Perspective, Is BIAF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has bioAffinity Technologies Stock Split?

bioAffinity Technologies has split 0 times.

How Many Employees Does bioAffinity Technologies Have?

bioAffinity Technologies has 57 employees.

What is the current trading status of bioAffinity Technologies (BIAF)?

As of 01 Aug 2025, bioAffinity Technologies (BIAF) is trading at a price of 0.29, with a previous close of 0.32. The stock has fluctuated within a day range of 0.28 to 0.32, while its 52-week range spans from 0.16 to 2.41.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.